BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17664872)

  • 1. The impact of general usage of stents on short- and long-term health care costs following percutaneous coronary intervention.
    Odell A; Landelius P; Astrom-Olsson K; Grip L
    Cardiology; 2008; 109(2):85-92. PubMed ID: 17664872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [What aspects are inefficient concerning percutaneous coronary intervention in Japan?: International cost-effectiveness comparisons].
    Chino M; Sakamoto M; Sasaki T; Isshiki T
    J Cardiol; 2004 Sep; 44(3):85-92. PubMed ID: 15500158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
    Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of functional testing strategy among stented and non-stented patients: insights from the ROSETTA Registry.
    Mak KH; Eisenberg MJ; Tsang J; Okrainiec K; Huynh T; Brown DL;
    Int J Cardiol; 2004 Jun; 95(2-3):321-7. PubMed ID: 15193839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost-effectiveness of coronary angioplasty procedures in Poland].
    Gasior M; Gierlotka M; Gasior U; Chodór P; Lekston A; Klosa Z; Balcarek J; Kalarus Z; Poloński L; Zembala M
    Kardiol Pol; 2004 Jul; 61(7):42-7; discussion 48. PubMed ID: 15338017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparison of early and late outcome of direct and conventional stenting of patients with st elevation myocardial infarction.
    Tacoy G; Yazici GE; Erden M; Timurkaynak T
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):181-6. PubMed ID: 19465441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing performance between coronary intervention centres requires detailed case-mix adjusted analysis.
    Denvir MA; Lee AJ; Rysdale J; Prescott RJ; Eteiba H; Walker A; Starkey IR; Pell JP
    J Public Health (Oxf); 2004 Jun; 26(2):177-84. PubMed ID: 15284323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic outcomes analysis of stenting versus percutaneous transluminal coronary angioplasty for patients with coronary artery disease in Japan.
    Ikeda S; Bosch J; Banz K; Schneller P
    J Invasive Cardiol; 2000 Apr; 12(4):194-9. PubMed ID: 10785672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
    Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term results of unprotected left main percutaneous coronary intervention with DES versus BMS.
    Capodanno D; Di Salvo ME; Capranzano P; Seminara D; Caggegi A; Barrano G; Tamburino C
    Minerva Cardioangiol; 2009 Feb; 57(1):1-6. PubMed ID: 19202514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of recent US cost estimates of revascularization.
    Nagle PC; Smith AW
    Am J Manag Care; 2004 Oct; 10(11 Suppl):S370-6. PubMed ID: 15603246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-eluting compared with bare-metal coronary stents among elderly patients.
    Groeneveld PW; Matta MA; Greenhut AP; Yang F
    J Am Coll Cardiol; 2008 May; 51(21):2017-24. PubMed ID: 18498954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting.
    Mack MJ; Prince SL; Herbert M; Brown PP; Katz M; Palmer G; Edgerton JR; Eichhorn E; Magee MJ; Dewey TM
    Ann Thorac Surg; 2008 Aug; 86(2):496-503; discussion 503. PubMed ID: 18640323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial.
    Kelbaek H; Kløvgaard L; Helqvist S; Lassen JF; Krusell LR; Engstrøm T; Bøtker HE; Jørgensen E; Saunamäki K; Aljabbari S; Thayssen P; Galløe A; Jensen GV; Thuesen L
    J Am Coll Cardiol; 2008 May; 51(21):2011-6. PubMed ID: 18498953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.
    Ma HY; Zhou YJ; Dick RJ; Shi DM; Liu YY; Cheng WJ; Guo YH; Wang JL; Ge HL
    Chin Med J (Engl); 2008 May; 121(10):887-91. PubMed ID: 18706201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and economic effects of coronary restenosis after percutaneous coronary intervention in a managed care population.
    Clark MA; Bakhai A; Pelletier EM; Cohen DJ
    Manag Care; 2005 Apr; 14(4):42-4, 46-51. PubMed ID: 15898211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of primary balloon angioplasty with bailout stenting strategy to primary coronary stenting strategy in the treatment of patients with ST-segment elevation myocardial infarction (STEMI).
    Tajstra M; Gasior M; Lekston A; Wilczek K; Hawranek M; Gierlotka M; Słonka G; Zebik T; Poloński L
    Kardiol Pol; 2007 Nov; 65(11):1277-84; discussion 1285-6. PubMed ID: 18058578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
    Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical economic considerations of coronary stenting.
    Szucs TD
    Schweiz Med Wochenschr; 1999 Nov; 129(45):1701-11. PubMed ID: 10595380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.